Prof. Tao Zhu 朱滔
Chief Physician, Professor
Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical, chemotherapy, and radiotherapy for cervical, ovarian, endometrial, vulvar, and vaginal cancers. Focuses on advanced and recurrent cases, robotic and laparoscopic surgery, fertility-sparing procedures, and nerve-sparing techniques.
Dr. Zhu is Chief Physician, Professor, and Vice President at Zhejiang Cancer Hospital, with clinical experience since 2000. A former visiting scholar at MD Anderson Cancer Center, Dr. Zhu specializes in minimally invasive gynecologic oncology surgery. Research interests include fertility-sparing and nerve-sparing procedures for young patients with early-stage or recurrent gynecologic malignancies.
Name order: in Chinese the family name comes first (Zhu Tao). Papers usually list the name as Tao Zhu or Zhu T.
Selected publications
71 papers on PubMed matched by name and affiliation; 16 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Surg, 2026 (senior author): Global trends and inequities in childhood cancer burden from 1990 to 2021, with projections to 2040: a Global Burden of Disease study. PubMed 41677339
- Int J Surg, 2026 (senior author): Green surgery: silencing the cry of the environment. PubMed 40844919
- World J Surg Oncol, 2025 (senior author): Predictive value of 18F-FDG-PET/CT for pathologic complete response (pCR) of lesions after neoadjuvant chemotherapy in advanced ovarian cancer. PubMed 41340060
- Curr Oncol, 2025 (senior author): PET/CT Imaging Characteristics of Gastric-Type Endocervical Adenocarcinoma: Findings from a Small Exploratory Series. PubMed 41149450
- BJOG, 2025 (senior author): Clinical Practice of Poly (ADP-Ribose) Polymerase Inhibitors for Maintenance Treatment of Platinum-Sensitive Recurrent Ovarian Cancer in China. PubMed 40313193
- Transl Cancer Res, 2025 (senior author): Ovarian cancer and malnutrition: a literature review. PubMed 40530143
- Cell Death Dis, 2025 (senior author): Eliminating VEGFA+ tumor-associated neutrophils by antibody-drug conjugates boosts antitumor immunity and potentiates PD-1 immunotherapy in preclinical models of cervical cancer. PubMed 39971940
- BMC Womens Health, 2024 (senior author): Prognostic factors of patients with recurrent uterine malignancies undergoing secondary cytoreductive surgery. PubMed 38166810
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion